胃旁路术与胃束带术后口服及静脉葡萄糖刺激下的胰岛素清除率
该研究在2型糖尿病患者中比较了Roux-en-Y胃旁路术(RYGB)与可调节胃束带术(AGB)对胰岛素清除率(ICR)的影响。研究显示,两种减重手术均显著提高空腹、口服葡萄糖及静脉葡萄糖刺激下的ICR,但RYGB术后静脉与口服ICR的差异更大,且内源性GLP-1可能参与调控RYGB术后餐后ICR。
要点
- 减重手术可提高T2DM患者的胰岛素清除率。
- RYGB术后胰岛素清除改善较AGB更明显。
- GLP-1可能调控RYGB术后餐后胰岛素清除。
核心结论
- 减重可提高胰岛素清除率,且RYGB术后效果较AGB更明显。
- 内源性GLP-1可能参与调控RYGB术后餐后胰岛素清除率。
研究设计与样本
- 研究1:在已建立的T2DM队列中,比较RYGB(n=22)与AGB(n=12)术前、匹配10%减重后及术后1年的空腹ICR、口服葡萄糖ICR和等血糖静脉葡萄糖钳夹ICR。
- 研究2:在另一T2DM队列(n=22)中,于RYGB术前及术后3个月,比较有或无exendin(9-39)输注时的口服ICR。
主要发现
- 研究1中,RYGB与AGB术前年龄、BMI、T2DM病程及控制情况和ICR均无差异。
- 术后1年RYGB减重程度是AGB的两倍(31.6 ± 5.9% vs. 16.6 ± 9.8%;P < 0.05)。
- RYGB和AGB术后1年均显著提高空腹ICR、口服ICR和静脉ICR。
- ICR与胰岛素血症呈负相关。
- RYGB术后静脉ICR与口服ICR的差异显著大于AGB。
临床怎么用
- 减重手术可改善T2DM患者胰岛素清除,RYGB改善幅度可能更大。
- GLP-1相关机制可能参与RYGB术后餐后胰岛素清除的调控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hepatic insulin clearance is a significant regulator of glucose homestasis. We hypothesized that the improvement in insulin clearance rates (ICRs) under fasting conditions and in response to oral and intravenous (IV) glucose would improve similarly after Roux-en-Y gastric bypass (RYGB) and adjustable gastric banding (AGB) as a function of weight loss; the difference in ICR after oral and IV glucose stimulation will be enhanced after RYGB compared with AGB, an effect mediated by glucagon-like peptide 1 (GLP-1). RESEARCH DESIGN AND METHODS: In study 1, the ICR was calculated under fasting condition (F-ICR), after oral glucose (O-ICR), and after an isoglycemic IV glucose clamp (IV-ICR) in individuals from an established cohort with type 2 diabetes mellitus (T2DM) before, after 10% matched weight loss, and 1 year after either RYGB (n = 22) or AGB (n = 12). In study 2, O-ICR was studied in a separate cohort of individuals with T2DM (n = 22), before and 3 months after RYGB, with and without exendin(9-39) infusion. RESULTS: In study 1, age, BMI, T2DM duration and control, and ICR did not differ between RYGB and AGB preintervention. Weight loss at 1 year was two times greater after RYGB than after AGB (31.6 ± 5.9% vs. 16.6 ± 9.8%; P < 0.05). RYGB and AGB both significantly increased F-ICR, O-ICR, and IV-ICR at 1 year. ICR was inversely associated with insulinemia. The difference between IV-ICR and O-ICR was significantly greater after RYGB versus AGB. GLP-1 antagonism with exendin(9-39) led to an increase in O-ICR in subjects post-RYGB. CONCLUSIONS: Weight loss increased ICR, an effect more pronounced after RYGB compared with AGB. Our data support a potential role for endogenous GLP-1 in the control of postprandial ICR after RYGB.
引用
- Shah A, Holter MM, Rimawi F, et al. Insulin Clearance After Oral and Intravenous Glucose Following Gastric Bypass and Gastric Banding Weight Loss. Diabetes Care. 2018. PMID: 30523032. doi:10.2337/dc18-1036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。